An experimental Alzheimer's drug shows promise targeting a different brain protein, new study shows

An experimental Alzheimer's drug shows promise targeting a different brain protein, new study shows
FacebookXWhatsAppEmail

An experimental drug might help slow early Alzheimer’s disease in a markedly different way than today’s treatments — by lowering levels of a brain protein called tau, researchers reported Tuesday.Tau is one part of a toxic duo fueling Alzheimer’s but prior attempts to develop drugs that can targe...